Molecular Chaperones in Cancer and Protein Quality Control Frontiers in Immunomodulation and Cancer Therapy (2nd edition)

Home | Events | CDK4/6 inhibition in pancreatic cancer: Effectiveness and molecular bases in combination with taxanes

CDK4/6 inhibition in pancreatic cancer: Effectiveness and molecular bases in combination with taxanes

Information

Date: 23/01/2019
Time 15:00
Venue: The Thesis will take place at IIB
Conference Speaker Beatriz Salvador
Institution Cell Division and Cancer Group, Molecular Oncology Programme
Supervised by Marcos Malumbres, Cell Division and Cancer Group-Manuel Hidalgo,Beth Israel Deaconess Medical Center
Free admission until full capacity is reached

Up